{"name":"Vitae Pharmaceuticals Inc., an Allergan affiliate","slug":"vitae-pharmaceuticals-inc-an-allergan-affiliate","ticker":"","exchange":"","domain":"","description":"Vitae Pharmaceuticals Inc., an Allergan affiliate, is a biopharmaceutical company focused on the discovery and development of novel small molecule drugs. The company's lead candidate, VTP-43742, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPMjctYmpoLTdoZG5Zc3BoV0w3YVZfS2pwN0lOOWNnR0ZZTzV5ekJRaGdKYVdpZXhNQ3RZb05QVG9rU3NNRXl0WEY4YWF6TU5mQmctQ3llazZOTElrN0RGZDZhT1lpVWtLRUttVmxPM1FJR3ViOG52ajVSZTBwZ3RFcV9WUUFXOEJ1QXliTnllbGxHOEE?oc=5","date":"2024-06-21","type":"pipeline","source":"SEC.gov","summary":"abbv-20221231xex21.htm - SEC.gov","headline":"abbv-20221231xex21.htm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPLVIxX3c1TUttd3RGckJDcEI5S0E3NGtQS3NaTDg0Q01QUUxENzh0eEFoLXlNSm5SdEpTY0UxeUNMOGxPLS1nZlZpN21peXlFVlloVmhsWFpPbF85aEJaV1hvT05EX1k3R1d4THVFRS04VzhkMExzZWNDVEZsdE5GYWUtUVVVb0NOZVYzaTQwb3V0bDBmWTVrT19Ud1hFMHpjS3B3eE1fYlpHZw?oc=5","date":"2016-10-25","type":"pipeline","source":"PR Newswire","summary":"Allergan Successfully Completes Vitae Tender Offer - PR Newswire","headline":"Allergan Successfully Completes Vitae Tender Offer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxQcmEyU1BjZzgtMGtBOFJWNENjWGJQYjhCM25FeFU2LXMzNjlLLTM3ekZyU0dVYVpiNDFuRUlUN1paQUVNNDVlTGZ1eXdYdTFkbF84M1pHY3BfZXFMSmo5czB0UlJqclpmNW5pNWlKekZVdmN1SU0ydXdodk1GQUtzN0x4dWZtdUxXZllid1JzdFJYOTA3ekZnVnNrLXdLSGhUcjRpSWlReGMzNUJlNS1EUkp0bjlVbl96Tjc2NFpYWU13aDBvaFZDUjJETlFfN2pSY2VMd2t6WnE3dWpMbXlSMG1rSHFrUUZoWGlyU3hQcTVnSXoxdVNV?oc=5","date":"2016-09-14","type":"deal","source":"PR Newswire","summary":"Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic Conditions - PR Newswire","headline":"Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic Conditions","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}